Delivery Order SPE2DB22D9239-SPE2DB24FDG69
Award Date 2/21/24
Potential Completion Date 3/13/24
Potential Value $9.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a potential value of $19,897.76 and a completion date of March 26, 2024. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) 4600082013 with DLA, a single-award vehicle valued up to $4,999,999 through 2025....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of EXPAREL 133 MG/10 ML VIAL 10ML. The firm fixed-price contract has a potential value of $8,566.92 and a completion date of March 19, 2024. This order is placed under DMS Pharmaceutical Group's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the DLA, contract 4600082013 under the SPE2DB program, which has a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $6,028.88 and a completion date of August 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. valued at $499,999,999, which enables the DLA to issue firm...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the provision of EXPAREL 266 MG/20 ML VIAL 20ML, with a firm fixed price of $4,205.74 and a completion date of March 14, 2024. The contract is not set aside for any specific business type. This delivery order is issued under DMS Pharmaceutical Group Inc.'s existing indefinite delivery contract with DLA,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, at a ceiling value of $4,974.44. The contract has a firm fixed price pricing type and an ultimate completion date of June 6, 2024. This award is associated with a larger indefinite delivery contract (IDC) between...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,057.76, is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a specialized pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant single-award...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $24,872.20, is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products to support the recurring medical supply needs of military health facilities. This contract is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $9,043.32 and a period of performance through May 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,948.88 contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a period of performance through December 11, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. The fixed-price contract has a ceiling value of $7,461.66 and a completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (SPE2DB) that DMS Pharmaceutical Group holds with the DLA, valued at up to $4,999,999 through the end of 2025, for the...